Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.

Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.

Cancer. 2004 Apr 15;100(8):1724-33.

2.

Concepts in use of high-dose methotrexate therapy.

Treon SP, Chabner BA.

Clin Chem. 1996 Aug;42(8 Pt 2):1322-9. Review.

3.

Methotrexate for high-grade osteosarcoma in children and young adults.

van Dalen EC, van As JW, de Camargo B.

Cochrane Database Syst Rev. 2011 May 11;(5):CD006325. doi: 10.1002/14651858.CD006325.pub3. Review.

PMID:
21563152
4.

Analysis of chemotherapy dosage and dosage intensity and survival outcomes of high-grade osteosarcoma patients younger than 40 years.

Sun L, Li Y, Li H, Zhang J, Li B, Ye Z.

Clin Ther. 2014 Apr 1;36(4):567-78. doi: 10.1016/j.clinthera.2014.02.018. Epub 2014 Mar 14. Review.

PMID:
24636527
5.

Methotrexate for high-grade osteosarcoma in children and young adults.

van Dalen EC, de Camargo B.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006325. doi: 10.1002/14651858.CD006325.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD006325.

PMID:
19160278
6.

Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.

Miser JS, Pritchard DJ, Rock MG, Shives TC, Gilchrist GS, Smithson WA, Arndt CA, Edmonson JH, Schaid DJ.

Cancer Treat Res. 1993;62:333-8. Review. No abstract available.

PMID:
8096748
7.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
8.

Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?

Anninga JK, Gelderblom H, Fiocco M, Kroep JR, Taminiau AH, Hogendoorn PC, Egeler RM.

Eur J Cancer. 2011 Nov;47(16):2431-45. doi: 10.1016/j.ejca.2011.05.030. Epub 2011 Jun 22. Review.

PMID:
21703851
9.

Therapy for osteosarcoma: where do we go from here?

Chou AJ, Geller DS, Gorlick R.

Paediatr Drugs. 2008;10(5):315-27. Review.

PMID:
18754698
10.

Osteogenic osteosarcoma: a model of curable disease by multidisciplinary approach of treatment.

Del├ępine N, Del├ępine G, Desbois JC, Cornille H, Jasmin C.

Biomed Pharmacother. 1990;44(5):243-8. Review.

PMID:
2091806
11.

Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review.

Pugi A, Benemei S, Vietri M, Tondo A, Calvani AM, Mugelli A, Vannacci A, Lapi F.

J Clin Pharm Ther. 2012 Apr;37(2):245-8. doi: 10.1111/j.1365-2710.2011.01275.x. Epub 2011 May 13. Review.

PMID:
21569069
12.

The role of methotrexate in osteosarcoma.

Grem JL, King SA, Wittes RE, Leyland-Jones B.

J Natl Cancer Inst. 1988 Jul 6;80(9):626-55. Review.

PMID:
3286880
13.

Pediatric and adult osteosarcoma: comparisons and contrasts in presentation and therapy.

Benjamin RS, Patel SR.

Cancer Treat Res. 2009;152:355-63. doi: 10.1007/978-1-4419-0284-9_19. Review.

PMID:
20213401
14.

Osteosarcoma and other tumors of bone.

Mertens WC, Bramwell V.

Curr Opin Oncol. 1995 Jul;7(4):349-54. Review.

PMID:
7578383
15.
16.

What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?

Chan BS, Dawson AH, Buckley NA.

Clin Toxicol (Phila). 2017 Feb;55(2):88-96. doi: 10.1080/15563650.2016.1271126. Review.

PMID:
28084171
17.

Development of acute myeloid leukemia after chemotherapy for osteosarcoma.

Kawai A, Sugihara S, Naito N, Ozaki T, Isu K, Hatae Y, Inoue H.

Clin Orthop Relat Res. 2001 Oct;(391):239-46. Review.

PMID:
11603675
18.
19.

Treatment-related leukoencephalopathy. A study of three cases and literature review.

Glass JP, Lee YY, Bruner J, Fields WS.

Medicine (Baltimore). 1986 May;65(3):154-62. Review.

PMID:
3517552
20.

Clinical pharmacokinetics and pharmacodynamics of anticancer agents in pediatric patients (review).

Knoester PD, Underberg WJ, Beijnen JH.

Anticancer Res. 1993 Sep-Oct;13(5C):1795-808. Review.

PMID:
8267385

Supplemental Content

Support Center